The EU Green Deal sets a high bar for reducing greenhouse gas (GHG) emissions, and its impact will be felt across industries. But the chemical sector’s unique nature...
Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will...
Novartis subsidiary Sandoz has launched a generic version of Combigan, the ocular hypertensiondrug made by AbbVie’s Allergan arm. The copy of the off-patent eye drops...
From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.
Since the middle of the 1980s, the supply chain of many chemicals has moved east. This was primarily driven by cheaper production costs in China or India, due to lower...
Pfizer has agreed to buy privately held, clinical-stage biopharma ReViral for up to $525 million, including upfront and development milestones. ReViral is focused on...
There can be no doubt that we are living through transformational times, driven by unprecedented disruptive events and the overall trends in society and markets.
British drugs giant GlaxoSmithKline (GSK) is buying US cancer treatment developer Sierra Oncology for £1.5 billion in a deal observers see as designed to fend off...
